Trial · NCT03819153
Results by group46
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 46
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
Number of Participants From Time of Randomization to First Occurrence of Onset of Persistent ≥50% Reduction in eGFR(CKD-EPI); Onset of Persistent eGFR(CKD-EPI) <15mL/Min/1.73m^2; Initiation of Chronic Renal Replacement Therapy; Renal Death; CV Death | Semaglutide | 331 | Participants | ||
Number of Participants From Time of Randomization to First Occurrence of Onset of Persistent ≥50% Reduction in eGFR(CKD-EPI); Onset of Persistent eGFR(CKD-EPI) <15mL/Min/1.73m^2; Initiation of Chronic Renal Replacement Therapy; Renal Death; CV Death | Placebo | 410 | Participants | ||
| Annual Rate of Change in eGFR (CKD-EPI) (Total eGFR Slope) | Semaglutide | -2.19 | Standard Error 0.1 | (mL/min/1.73 m^2)/year | |
| Annual Rate of Change in eGFR (CKD-EPI) (Total eGFR Slope) | Placebo | -3.36 | Standard Error 0.1 | (mL/min/1.73 m^2)/year | |
| Number of Participants From Time of Randomization to Occurrence of Onset of Persistent ≥50% Reduction in eGFR (CKD-EPI) | Semaglutide | 165 | Participants | ||
| Number of Participants From Time of Randomization to Occurrence of Onset of Persistent ≥50% Reduction in eGFR (CKD-EPI) | Placebo | 213 | Participants | ||
| Number of Participants From Time of Randomization to Occurrence of Onset of Persistent eGFR (CKD-EPI) <15mL/Min/1.73m^2 | Semaglutide | 92 | Participants | ||
| Number of Participants From Time of Randomization to Occurrence of Onset of Persistent eGFR (CKD-EPI) <15mL/Min/1.73m^2 | Placebo | 110 | Participants | ||
| Number of Participants From Time of Randomization to Occurrence of Initiation of Chronic Renal Replacement Therapy | Semaglutide | 87 | Participants | ||
| Number of Participants From Time of Randomization to Occurrence of Initiation of Chronic Renal Replacement Therapy | Placebo | 100 | Participants | ||
| Number of Participants From Time of Randomization to Occurrence of Renal Death | Semaglutide | 5 | Participants | ||
| Number of Participants From Time of Randomization to Occurrence of Renal Death | Placebo | 5 | Participants | ||
| Number of Participants From Time of Randomization to Occurrence of CV Death | Semaglutide | 123 | Participants | ||
| Number of Participants From Time of Randomization to Occurrence of CV Death | Placebo | 169 | Participants | ||
| Annual Rate of Change in eGFR (Chronic Kidney Disease CKD-EPI) (Chronic eGFR Slope) | Semaglutide | -2.36 | Standard Error 0.1 | mL/min/1.73 m^2 | |
| Annual Rate of Change in eGFR (Chronic Kidney Disease CKD-EPI) (Chronic eGFR Slope) | Placebo | -3.30 | Standard Error 0.1 | mL/min/1.73 m^2 | |
| Change From Baseline in eGFR (CKD-EPI) at Week 12 | Semaglutide | -1.07 | Standard Deviation 8.16 | mL/min/1.73m^2 | |
| Change From Baseline in eGFR (CKD-EPI) at Week 12 | Placebo | -1.07 | Standard Deviation 7.73 | mL/min/1.73m^2 | |
| Change From Baseline in eGFR (Cystatin C CKD-EPI) at Week 104 | Semaglutide | -2.1 | Standard Deviation 11.4 | mL/min/1.73m^2 | |
| Change From Baseline in eGFR (Cystatin C CKD-EPI) at Week 104 | Placebo | -5.4 | Standard Deviation 9.7 | mL/min/1.73m^2 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03819153/results